Human papillomavirus vaccine (Oryx)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameHuman papillomavirus vaccine (Oryx)

Drug Alias NameVicOryx人乳头瘤病毒疫苗 - Oryxp16INK4a peptide vaccine人类乳突病毒疫苗 - Oryxp16INK4a-37-63

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Recombinant vector vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Heidelberg

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesOryx Gmbh & Co Kg

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A